| Simvastatin with or without ezetimibe in familial hypercholesterolemia JJP Kastelein, F Akdim, ESG Stroes, AH Zwinderman, ML Bots, ... New England Journal of Medicine 358 (14), 1431-1443, 2008 | 1699 | 2008 |
| A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation R Duivenvoorden, J Tang, DP Cormode, AJ Mieszawska, ... Nature communications 5 (1), 3065, 2014 | 451 | 2014 |
| COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ... Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020 | 417 | 2020 |
| Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA ERACODA Working Group Duivenvoorden Raphaël Franssen Casper FM Hemmelder ... Nephrology Dialysis Transplantation 36 (1), 87-94, 2021 | 359 | 2021 |
| Trained immunity, tolerance, priming and differentiation: distinct immunological processes M Divangahi, P Aaby, SA Khader, LB Barreiro, S Bekkering, T Chavakis, ... Nature immunology 22 (1), 2-6, 2021 | 355 | 2021 |
| Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis E De Groot, SI Van Leuven, R Duivenvoorden, MC Meuwese, F Akdim, ... Nature clinical practice Cardiovascular medicine 5 (5), 280-288, 2008 | 350 | 2008 |
| Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation J Tang, ME Lobatto, L Hassing, S Van Der Staay, SM Van Rijs, ... Science advances 1 (3), e1400223, 2015 | 225 | 2015 |
| Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance MS Braza, MMT van Leent, M Lameijer, BL Sanchez-Gaytan, RJW Arts, ... Immunity 49 (5), 819-828. e6, 2018 | 194 | 2018 |
| ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial MC Meuwese, E de Groot, R Duivenvoorden, MD Trip, L Ose, FJ Maritz, ... Jama 301 (11), 1131-1139, 2009 | 167 | 2009 |
| Targeting CD40-induced TRAF6 signaling in macrophages reduces atherosclerosis TTP Seijkens, CM van Tiel, PJH Kusters, D Atzler, O Soehnlein, ... Journal of the American College of Cardiology 71 (5), 527-542, 2018 | 156 | 2018 |
| Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy Y Zhao, F Fay, S Hak, J Manuel Perez-Aguilar, BL Sanchez-Gaytan, ... Nature communications 7 (1), 11221, 2016 | 128 | 2016 |
| Increased plasma heparanase activity in COVID-19 patients B Buijsers, C Yanginlar, A de Nooijer, I Grondman, ML Maciej-Hulme, ... Frontiers in immunology 11, 575047, 2020 | 119 | 2020 |
| In vivo quantification of carotid artery wall dimensions: 3.0-Tesla MRI versus B-mode ultrasound imaging R Duivenvoorden, E De Groot, BM Elsen, JS Laméris, RJ Van Der Geest, ... Circulation: Cardiovascular Imaging 2 (3), 235-242, 2009 | 116 | 2009 |
| Immune cell screening of a nanoparticle library improves atherosclerosis therapy J Tang, S Baxter, A Menon, A Alaarg, BL Sanchez-Gaytan, F Fay, Y Zhao, ... Proceedings of the National Academy of Sciences 113 (44), E6731-E6740, 2016 | 114 | 2016 |
| Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates M Lameijer, T Binderup, MMT Van Leent, ML Senders, F Fay, J Malkus, ... Nature biomedical engineering 2 (5), 279-292, 2018 | 108 | 2018 |
| Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition B Priem, MMT van Leent, AJP Teunissen, AM Sofias, VP Mourits, ... Cell 183 (3), 786-801. e19, 2020 | 103 | 2020 |
| In vivo PET imaging of HDL in multiple atherosclerosis models C Pérez-Medina, T Binderup, ME Lobatto, J Tang, C Calcagno, L Giesen, ... JACC: Cardiovascular Imaging 9 (8), 950-961, 2016 | 102 | 2016 |
| Trained immunity—basic concepts and contributions to immunopathology J Ochando, WJM Mulder, JC Madsen, MG Netea, R Duivenvoorden Nature Reviews Nephrology 19 (1), 23-37, 2023 | 88 | 2023 |
| ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden AE Bochem, DF van Wijk, AG Holleboom, R Duivenvoorden, ... European heart journal 34 (4), 286-291, 2013 | 81 | 2013 |
| Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study J Bucerius, R Duivenvoorden, V Mani, C Moncrieff, JHF Rudd, ... JACC: Cardiovascular Imaging 4 (11), 1195-1205, 2011 | 81 | 2011 |
